Please be advised that our strategic supplier, Cell Signaling Technology, Inc., implemented a price increase effective January 1, 2026.

As part of our ongoing supplier relationship management, the University’s Strategic Procurement team works closely with suppliers to ensure pricing remains aligned with market conditions and operational costs. Cell Signaling Technology has communicated that this adjustment is necessary due to continued investments in production and supply chain capabilities to maintain industry-leading fulfillment and delivery performance.

Summary of Supplier Rationale:

• Cell Signal Technology manufactures over 95% of antibodies in-house, ensuring control over production, validation, and fulfillment.
• Recent investments are aimed at minimizing lead times and sustaining over 99% on-time delivery.
• To support these enhancements, Cell Signal Technology will implement a moderate catalog price increase of 3.4%.

If you have any questions or need further information, please contact Alicia Braveheart, Strategic Sourcing Specialist for Scientific & Research, at alicia.braveheart@cu.edu